Summary: <br> <a href="https://twitter.com/intent/tweet?url=http%3A%2F%2Fwww.talkingbiotechpodcast.com%2F256-communicating-covid19-careful-with-cancellation%2F&via=talkingbiotech" class="twitter-share-button" data-size="large">Tweet</a><br> <a href="https://i0.wp.com/www.talkingbiotechpodcast.com/wp-content/uploads/2020/09/256-me-cover.jpg"></a><br> This week’s guest is the host! It was important to discuss communication tips during a pandemic, especially around popular myths and news stories involving COVID19. Kevin Folta provides counterarguments to today’s most prevalent claims around hydroxychloroquine, disease incidence, and the flu shot. It also marks five years since the New York Times story that portrayed Folta as a corporate patsy. While many aspects of his research and communications efforts thrive today, this deliberate act of cancel-culture now diminishes his impact in other arenas, such as discussing COVID19. This is a rallying cry for more scientists and science enthusiasts to engage the public with science communication.<br> <br>
